Qualified startups are those founded or led by MIT faculty, staff, or alumni, or are based on MIT-licensed technology and are positioned for significant growth. Check the background of this firm on FINRA’s BrokerCheck. business or any State in which this notice is filed. Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward. sponsored by Arbor Biotechnologies, Inc.. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. * This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. ARCH Venture Partners invests primarily in companies located in the southwestern, Midwestern, eastern seaboard and northwestern sections of the US. © 2020 BioCentury Inc. All Rights Reserved. Based in Cambridge, MA, Arbor is unlocking nature’s genetic diversity to create transformative products in human health and sustainability. About Arbor Biotechnologies . New RNA CRISPR Tool Normalizes Tau Splicing, Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform. EquityZen Inc.30 Broad Street,Suite 1200New York, NY 10004support@equityzen.com, Multinational pharmaceutical and life sciences company. The Arbor Biotechnologies Selected For MIT STEX25 CAMBRIDGE, Mass., July 09, 2019 (GLOBE NEWSWIRE) -- Arbor Biotechnologies (Arbor), an early-stage biodiscovery company, announced today that it has been selected for STEX25, an MIT Startup Exchange featuring 25 industry-ready startups that are poised for significant growth. Twelve Bio: Building a plug-and-play CRISPR platform with Cas12a variants, Exonics takeout, expanded CRISPR deal vault Vertex into neuromuscular diseases, Vertex moving into protein degradation with Kymera collaboration, Vertex builds CRISPR toolbox with Merck KGaA deal, Arbor launches with $15.6 million, new CRISPR enzyme. Arbor Biotechnologies is an early-stage life sciences company harnessing the power of nature to solve complex challenges across a range of industries. materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority. Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, 505(b)(2)(iii) or Rule 506(d). Developer of transformative therapeutic products designed to improve human health and sustainability. Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? Industry participants are principally members of MIT’s Industrial Liaison Program (ILP). Our salaries are competitive, our benefits are generous, and our team is exceptional. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA. 3416 (Oct. Watch live: US health officials speak before Senate committee on the coronavirus... Vor Biopharma and Arbor Biotechnologies to Collaborate on Engineered Hematopoietic Stem-Cell Therapies, DNA Read, Write and Edit Market Study (2017-2024) with 320+ Companies Profiled - ResearchAndMarkets.com, Arbor Biotechnologies Announces Issuance of U.S. Patent for CRISPR-Cas13d, Arbor Biotechnologies Selected For MIT STEX25. Arbor Biotechnologies General Information Description. Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. Arbor’s proprietary platform integrates a computational search engine with high-throughput experimental capabilities to enable both rapid protein characterization and product generation. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform. Minimum investment accepted from any outside investor, State(s) of Solicitation (select all that apply). The MIT Startup Exchange actively promotes collaboration and partnerships among the 1,700 MIT-connected startups and industry resources. How do you describe Arbor to friends? Federal Exemption(s) and Exclusion(s) Claimed (select all that apply), 9. Arbor Biotechnologies is an early-stage company pushing the boundaries of biodiscovery. Certain Information provided by Factset Research System Inc. ONF Unveils Aether(TM) the First Open Source Platform for 5G/LTE-Edge-Cloud-as-a... Organization for Economic Cooperation and Development, Virus spread prompts Fed to slash rates in surprise move. Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of Explore notable alumni from top universities and organizations. Arbor joins eight other companies chosen for the current session. Jul 23, 2018. The reader should not assume that the information is accurate and complete. Discover the Power of Your Network with RelSci Premium Products. business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and Title 17 of the Code of Federal Regulations. May 23, 2018. TeselaGen is accelerating the design and fabrication of DNA with synthetic biology software. On Jan. 3, Vertex announced a deal with. already have invested in the offering. ...bacterial DNA at low attomolar concentrations. Investors must be able to afford the loss of their entire investment. Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. any kind between RelSci and Arbor Biotechnologies, Inc.. © 2020 Relationship Science LLC. Their physical sciences investments focus on companies that are pioneering technology with a range of commercial applications in chemicals/materials, electronics/instrumentation and medical instrumentation industries. © 2020 PitchBook Data. Based in Cambridge, MA, Arbor is unlocking nature’s genetic diversity to create transformative products in human health and sustainability. Empower Your Business Applications with Industry-Leading Relationship Data from the RelSci API. The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized None. New York, NY 10001. Arbor Biotechnologies, Inc. Street Address 1 Street Address 2; 790 MEMORIAL DRIVE: SUITE 2E: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02139: 307-690-6660 have invested in the offering: In submitting this notice, each issuer named above is: Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable Arbor Biotechnologies was founded on the premise that there exists an abundance of biodiversity capable of powering solutions in human health and sustainability—and it’s just waiting to be harnessed. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA. Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice. ARCH Venture Partners focuses on seed and early-stage investments in start-up technology companies, with a particular interest in the life sciences, the physical sciences and information technology. Jan 3, 2019. A second study published the same day in Molecular Cell by. Name * First Name The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. Find RelSci relationships, employment history, board memberships, donations, awards, and more. ...diagnostics space. This web site is not endorsed by, directly affiliated with, maintained, authorized, or U.S. Federal Reserve Cuts Interest Rate by Half-Percentage Point Amid Coronaviru... Israeli exit polls: Netanyahu ahead, but short of majority. Alzforum - Mar, 23 2018. Principal Place of Business and Contact Information. CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care. Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. June 2017: $12.2M: Press. instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering Arbor Biotechnologies is an early-stage company pushing the boundaries of biodiscovery. L. No. © 2020 Relationship Science LLC. Jul 23, 2018. Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of Other companies, including, ...Into Protein Degradation with Kymera Collaboration” ). To view Arbor Biotechnologies’s complete valuation and funding history, request access », To view Arbor Biotechnologies’s complete cap table history, request access », You’re viewing 5 of 6 executive team members.